Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Escudier

Showing results (11-20 of 362) with videos related to

Pageof 37
Sort By:
Clinical Advances in Hematology & Oncology : H&O|November 26, 2009
New therapies after failure of angiogenesis inhibitorsBernard Escudier
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Signaling inhibitors in metastatic renal cell carcinomaBernard Escudier
Oncology (Williston Park, N.Y.)|May 2, 2012
Metastatic RCC: moving towards a chronic diseaseBernard Escudier
World Journal of Urology|June 13, 2008
Comments on the article "Targeted therapy in renal cell carcinoma" by J.-J. Patard et alBernard Escudier
Drugs in R&D|June 18, 2011
Axitinib for the management of metastatic renal cell carcinomaBernard Escudier, Martin Gore
Drugs|June 30, 2011
Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinomaBernard Escudier, Laurence Albiges
The Lancet. Oncology|December 11, 2012
Prognosis of renal-cell carcinoma: recognising host geneticsGuru Sonpavde, Bernard Escudier
European Urology|August 10, 2016
Assessment of Early Tumour Shrinkage: Ready for Integration in the Treatment Strategy for Metastatic Renal Cell Carcinoma?Laurence Albiges, Bernard Escudier
Seminars in Oncology|August 27, 2013
Sequencing therapy in metastatic renal cell cancerBernard Escudier, Martin Gore
European Urology|September 12, 2017
New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far?Bernard Escudier, Michael Staehler
Pageof 37

Showing results (11-20 of 362) with videos related to

Sort By:
Pageof 37
Clinical Advances in Hematology & Oncology : H&O|November 26, 2009
New therapies after failure of angiogenesis inhibitorsBernard Escudier
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Signaling inhibitors in metastatic renal cell carcinomaBernard Escudier
Oncology (Williston Park, N.Y.)|May 2, 2012
Metastatic RCC: moving towards a chronic diseaseBernard Escudier
World Journal of Urology|June 13, 2008
Comments on the article "Targeted therapy in renal cell carcinoma" by J.-J. Patard et alBernard Escudier
Drugs in R&D|June 18, 2011
Axitinib for the management of metastatic renal cell carcinomaBernard Escudier, Martin Gore
Drugs|June 30, 2011
Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinomaBernard Escudier, Laurence Albiges
The Lancet. Oncology|December 11, 2012
Prognosis of renal-cell carcinoma: recognising host geneticsGuru Sonpavde, Bernard Escudier
European Urology|August 10, 2016
Assessment of Early Tumour Shrinkage: Ready for Integration in the Treatment Strategy for Metastatic Renal Cell Carcinoma?Laurence Albiges, Bernard Escudier
Seminars in Oncology|August 27, 2013
Sequencing therapy in metastatic renal cell cancerBernard Escudier, Martin Gore
European Urology|September 12, 2017
New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far?Bernard Escudier, Michael Staehler
Pageof 37